We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 215.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JZCP agrees amendments to its Senior Facility

23 Oct 2020 07:00

JZ Capital Partners Ltd - JZCP agrees amendments to its Senior Facility

JZ Capital Partners Ltd - JZCP agrees amendments to its Senior Facility

PR Newswire

London, October 22

JZ CAPITAL PARTNERS LIMITED(a closed-end collective investment scheme incorporated with limited liability under the laws of Guernsey with registered number 48761)LEI: 549300TZCK08Q16HHU44

JZCP agrees amendments to its Senior Facility

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 ("MAR").

 23 October 2020

JZ Capital Partners Limited ("JZCP" or the "Company"), the London listed fund that invests in US and European micro-cap companies and US real estate, is today pleased to announce that it has reached agreement with its senior lenders to amend the terms of its existing senior facility agreement (the "Senior Facility").

As announced on 8 October 2020, the Company had breached its minimum asset coverage ratio under the Senior Facility and was also in default under the facility having not agreed to amended terms with its senior lenders by 7 October 2020. It was also noted in that announcement that, if the existing or any other event of default under the Senior Facility were to continue, the Company would be prohibited from making payments to the holders of its Convertible Unsecured Loan Stock due 2021 ("CULS") on any subsequent CULS interest payment date, absent either a waiver, a further consent or the amended terms of the facility allowing for such payments to be made.

The Company is however now pleased to announce that its senior lenders have waived the Company's aforementioned and other technical breaches and defaults, with agreement also having been reached as to the amended terms of the Senior Facility by way of the Company's entry into an amendment agreement to the facility (the "Amended Senior Facility) with, among others, Guggenheim Partners Europe Limited as a senior lender, administrative agent for the senior lenders and collateral agent.

Under the terms of the Amended Senior Facility, approximately US$40 million of the outstanding principal amount of approximately US$150 million under the Senior Facility has been assigned from the existing lenders to clients and funds advised by Cohanzick Management, LLC and CrossingBridge Advisors, LLC. The replacement lenders (of approximately US$40 million of the outstanding principal amount) have agreed, pursuant to an agreement among lenders, to be subordinated to the existing lenders (of approximately US$110 million of the outstanding principal amount) under the Amended Senior Facility. In exchange, it has been agreed under the Amended Senior Facility that the interest rate payable by the Company for the loans funded by the replacement lenders will accrue interest at a rate of Libor + 11.00%, instead of Libor + 5.75% as is applicable to the existing lenders.

The Company has in turn secured more advantageous terms for itself including the minimum asset coverage covenant being reset (from not less than 4.00:1.00 to a lower threshold of initially not less than 3.25 to 1.00 and from completion of the recently announced Secondary Sale or 7 December 2020, whichever is earlier, not less than 3.50:1.00) and a relaxation of rating requirements, removal of certain concentration limits, updates to the use of proceeds requirements pertaining to asset sales to preserve liquidity, and reduced requirements related to its real estate collateral and reporting on investments. The Company has also agreed to certain limitations on permitted investments going forwards (consistent with its recently amended and restated investment policy), reductions to its permitted unsecured indebtedness and encumbrances, and certain restrictions on dividends until the senior debt is repaid.

In addition, as part of the recently announced Secondary Sale, which is expected to close following approval of the Company's ordinary shareholders in early December 2020, the Company has agreed that US$70 million of any proceeds received by the Company from that sale and other recent sales will be used to repay the senior lenders. As mentioned above, the replacement lenders will be subordinated to the existing lenders under the Amended Senior Facility and as such the repayment of any such proceeds of US$70 million will first be applied to the existing lenders, such that thereafter the outstanding loans from the existing lenders will be reduced from approximately US$110 million to approximately US$40 million and the outstanding loans from the replacement lenders will remain at approximately US$40 million. Completion of the Secondary Sale by 7 December 2020 is, among others, a condition subsequent of the Amended Senior Facility.

The term of the Amended Senior Facility remains as expiring on 12 June 2021 with repayment falling due on the same date, albeit with the possibility of extension in certain limited circumstances.

For completeness, the Company notes that following completion of the Secondary Sale and use of any proceeds therefrom and other recent sales to make the repayment of US$70 million to the existing lenders under the Amended Senior Facility, the Company’s approximate key debt obligations will be as follows: (i) senior debt of approximately US$80 million pursuant to the Amended Senior Facility (due 12 June 2021), (ii) CULS of approximately £38.9m (due 30 July 2021), and (iii) the Company's Zero Dividend Preference Shares of approximately £57.6m (due 1 October 2022).

Also for completeness and by reference to its earlier announcements, the Company last of all notes that, as at this time it is no longer in default under the Senior Facility, the Company is currently no longer prohibited from making interest payments to the holders of the CULS. The Company will also be continuing to make announcements as required in relation to developments and the realisation of its strategy as matters progress.

Market Abuse Regulation:

The information contained within this announcement is inside information as stipulated under MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of JZCP is David Macfarlane, Chairman of JZCP.

For further information:

Ed Berry FTI Consulting+44 (0) 20 3727 1046
David Zalaznick Jordan/Zalaznick Advisers, Inc.+1 (212) 485 9410
Sam Walden Northern Trust International Fund Administration Services (Guernsey) Limited+44 (0)1481 745385

Important Notice

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements relate to matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual investment performance, results of operations, financial condition, liquidity, policies and the development of its strategies may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the investment performance, result of operations, financial condition, liquidity and policies of the Company and development of its strategies, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods. These forward-looking statements speak only as at the date of this announcement. Subject to their legal and regulatory obligations, each of the Company, the Investment Adviser and their respective affiliates expressly disclaims any obligations to update, review or revise any forward-looking statement contained herein whether to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based or as a result of new information, future developments or otherwise.

Date   Source Headline
16th Oct 20137:00 amRNSNet Asset Value(s)
16th Oct 20137:00 amRNSHalf Yearly Report
27th Sep 201310:45 amRNSNotice of Interim Results
4th Sep 20138:45 amRNSExpansion of European Portfolio
21st Aug 20139:00 amRNSNet Asset Value(s)
16th Jul 20137:00 amRNSNet Asset Value(s)
25th Jun 20137:00 amRNSInterim Management Statement
24th Jun 20136:15 pmRNSResult of AGM
28th May 20136:09 pmRNSReplacement - Net Asset Value(s)
28th May 20134:30 pmRNSNet Asset Value(s)
22nd May 20134:00 pmRNSNotice of AGM and Annual Accounts to NSM
22nd May 20131:30 pmRNSDirector/PDMR Shareholding
21st May 20138:08 amRNSFinal Results
21st May 20137:01 amRNSDividend Declaration
14th May 20137:00 amRNSNet Asset Value(s)
29th Apr 20139:48 amRNSDirector Change/Update
10th Apr 20139:43 amRNSNotice of Results
25th Mar 201311:15 amRNSNet Asset Value(s)
19th Feb 20136:15 pmRNSHolding(s) in Company
5th Feb 201312:48 pmRNSDirector Declaration
17th Jan 201310:00 amRNSNet Asset Value(s)
19th Dec 20125:17 pmRNSNet Asset Value(s)
19th Dec 20127:00 amRNSInterim Management Statement
19th Nov 201211:30 amRNSNet Asset Value(s)
14th Nov 20121:45 pmRNSDirector/PDMR Shareholding
30th Oct 20127:00 amRNSHalf Yearly Report to NSM
19th Oct 201212:03 pmRNSNet Asset Value(s)
10th Oct 20124:00 pmRNSDirector/PDMR Shareholding
10th Oct 201210:00 amRNSDividend Declaration
10th Oct 20127:00 amRNSInterim Results
25th Sep 201210:15 amRNSNet Asset Value(s)
21st Sep 20128:56 amRNSNotice of Results
4th Sep 20123:43 pmRNSChange of Registered Office and Service Provider
24th Aug 20129:16 amRNSNet Asset Value(s)
31st Jul 20124:32 pmRNSTotal Voting Rights
24th Jul 20129:26 amRNSHolding(s) in Company
23rd Jul 20124:30 pmRNSHolding(s) in Company
23rd Jul 20124:05 pmRNSNet Asset Value(s)
20th Jul 201210:21 amRNSTotal Voting Rights
5th Jul 20129:15 amRNSNet Asset Value(s)
4th Jul 20127:00 amRNSInterim Management Statement
3rd Jul 20124:47 pmRNSAnnual General Meeting
3rd Jul 20123:25 pmRNSResults of Second General Meeting
3rd Jul 201211:43 amRNSResults of First General Meeting
7th Jun 20129:36 amRNSNet Asset Value(s)
1st Jun 20124:55 pmRNSHolding(s) in Company
22nd May 201212:31 pmRNSDirector/PDMR Shareholding
18th May 20127:02 amRNSProposed admission and other strategic initiatives
18th May 20127:01 amRNSDividend declaration
18th May 20127:00 amRNSFull Year Results 2011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.